Medical Condition News

RSS

Study: HBV genotype is not linked to hepatocellular carcinoma

Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. It is likely that this depends on the HBV genotype distribution in certain region.

17 Sep 2009

Educational initiative proves successful in identifying and diagnosing fibromyalgia

According to The Johns Hopkins University School of Medicine, the Fibromyalgia Circle of Care Initiative has achieved dramatic success in heightening awareness, diagnosis and best practice treatment of fibromyalgia – a complex and chronic pain disorder that plagues an estimated 10 million Americans.

17 Sep 2009

UPV provides new model to recognize postnatal depression

Worldwide, 13% of women who give birth suffer from postnatal depression, which causes a significant deterioration in a mother's quality of life and her ability to care for her baby. Now, Spanish researchers have developed a model to diagnose this illness with a predictive power of 80% - the best result to date for this kind of depression.

17 Sep 2009

Cancer patients struggles with huge drug costs

Canada's patchwork system of drug coverage is leading to financial hardship for many cancer patients, says a Canadian Cancer Society report released today.

17 Sep 2009

Deterioration in brain function following breast cancer therapy affects quality of life: Study

One of the most problematic side effects of cancer treatment, chemobrain - a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning.

17 Sep 2009

GENova Biotherapeutics signs collaboration deal with Beckpharma

GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed a collaboration deal with Beckpharma Ltd.

17 Sep 2009

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Today the Alzheimer Society gives greater meaning to your daily dose of caffeine. By purchasing a cup of coffee during the Alzheimer Coffee Break(R) fundraiser you will be supporting critical programs and services for the half million Canadians living with Alzheimer's disease or related dementias.

17 Sep 2009

The Ontario Government must act to reduce the financial barrier to mental health services: MFH

Financial barriers can be immense for people who suffer from mental illness and the Ontario Government has an opportunity to act now. The All-Party Committee on Mental Health and Addictions is hearing from groups and individuals on what should be included in a strategy for the province.

17 Sep 2009

CHUM installs CyberKnife system for effective cancer treatment in Canada

Accuray Incorporated, a global leader in the field of radiosurgery today announced that Centre Hospitalier de l'Universite de Montreal (CHUM) has installed a CyberKnife(R) Robotic Radiosurgery System at Hopital Notre-Dame du CHUM, in Montreal, Canada.

17 Sep 2009

Glaxo conceals risks: Antidepressant drug Paxil causes birth defects

Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.

17 Sep 2009

Advanced radiosurgery technology utilized by Cyberknife for effective cancer treatment

Cyberknife of Long Island has become the first cancer center in New York to treat tumors with the most advanced radiosurgery technology available to date.

17 Sep 2009

Workshop to educate women on urinary incontinence

UCSF and the National Association For Continence (NAFC) are holding a public workshop on October 3 to help women understand how they can control and treat incontinence.

17 Sep 2009

Charley's Fund and the Nash Avery Foundation to support investigation of Galapagos' SARM candidate drug

Galapagos NV (Euronext: GLPG), Charley's Fund Inc. and the Nash Avery Foundation announced today that they will collaborate to investigate the potential effectiveness of Galapagos' SARM candidate drug, G100192, in treating Duchenne muscular dystrophy. G100192 is an orally-available small molecule therapeutic, which has demonstrated successful Proof of Concept in pre-clinical studies for cachexia (the loss of weight and muscle mass).

17 Sep 2009

Underlying malignancies can cause rebleeding after negative angiography

Acute non-variceal gastrointestinal bleeding accounts for approximately 20% of emergency room visits and 5% of admissions. Although endoscopy has been used as a first-line treatment option in patients with gastrointestinal bleeding, angiographic intervention can be used as a safe diagnostic and treatment method in patients with gastrointestinal bleeding that is refractory to endoscopic treatment.

17 Sep 2009

Study focuses on hypertension

How high blood pressure develops and the effects it has on the body are the focus of a two-part study underway at Penn State and Johns Hopkins University that will look at hypertension in the human body and in the laboratory.

17 Sep 2009

Guide reveals that non-smokers require different treatment for lung cancer

A committee of scientists led by Johns Hopkins investigators has published a new guide to the biology, diagnosis and treatment of lung cancer in never-smokers, fortifying measures for what physicians have long known is a very different disease than in smokers.

17 Sep 2009

FDA issues a complete response letter for Sanofi-aventis' eplivanserin NDA

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.

17 Sep 2009

FDA provides PMA approval for Spectrascience's WavSTAT technology enhancements

SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that its application for premarket approval (PMA) relating to key enhancements of its WavSTAT platform technology has been approved by the Food and Drug Administration. The Company can now begin commercial distribution of the enhanced WavSTAT technology.

17 Sep 2009

Melbourne's national approach for managing chronic pain

An unprecedented gathering of some of Australia's leading authorities in pain medicine, together with consumer groups representing chronic pain sufferers, will meet in Melbourne today to work towards a national, coordinated approach to managing chronic pain.

17 Sep 2009

Expo East 2009 conference to focus on integrative cancer care model

People diagnosed with cancer have a number of treatment options to choose from and increasingly, alternative and complementary therapies such as yoga, meditation, healing touch, music therapy, and nutritional supplementation are among them.

17 Sep 2009